~~<i id='34744F67AF'><strike id='34744F67AF'><tt id='34744F67AF'><pre id='34744F67AF'></pre></tt></strike></i>~~

Home» focus» explore

explore

author：Wikipedia 2025-09-27 22:16:15 Page View：6293

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby
Next article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

knowledge

Jerome Adams on the need for new antivirals for Covid

PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

With clinical trial data readouts, here's how to spot spin

AdobeInvestors,analysts,doctors,andevenpatientsfaceanavalancheofnewsfrombiotechcompaniesabouttheirhu

Affirmative action in medical school literally saved lives

AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

ActorKevinSpaceyarrivesatSouthwarkCrownCourtwhereheisaccusedofsexualoffensesagainstfourmenwhilehewor